T80.419
Rh incompatibility with hemolytic transfusion reaction, unspecified
Clinical Classification Guidelines
Inclusion Terms
- Rh incompatibility with hemolytic transfusion reaction at unspecified time after transfusion
- Hemolytic transfusion reaction (HTR) due to Rh incompatibility NOS
Medical Intelligence & Overview
Rh incompatibility with hemolytic transfusion reaction (ICD-10 Code T80.419) is a medical condition that can occur after a blood transfusion. It involves an immune response where the recipient's antibodies attack transfused red blood cells due to Rh incompatibility. This reaction can lead to hemolysis, the destruction of blood cells, which may cause serious health issues if not properly managed. This explanation aims to provide clear and patient-friendly information about this condition.
Causes & Symptoms
Clinical Causes: Receiving blood transfusions from a donor with incompatible Rh blood group (most commonly Rh-positive blood given to an Rh-negative recipient). Previous sensitization to Rh-positive blood, leading to the development of antibodies. Inadequate blood testing or labeling errors that result in incompatible blood transfusion.
Key Symptoms: Fever and chills following a blood transfusion. Back pain or flank pain indicating kidneys' involvement. Dark urine, which may appear tea-colored or brown due to hemolysis. General symptoms like fatigue, weakness, or pallor. In severe cases, shortness of breath, rapid heartbeat, or signs of shock.
Diagnostic & Treatment
Diagnosis Path: Diagnosis typically involves recognizing symptoms after a transfusion and confirming hemolytic reaction through laboratory tests. These tests may include:
Treatment Protocols: Treatment focuses on managing the reaction and preventing complications. It may include:
Clinical Advice & FAQs
Billing Guidance
Is T80.419 a billable ICD-10 code?
Yes, T80.419 is a specific, billable code that can be used to indicate a diagnosis for reimbursement purposes.
Documentation
How do I report T80.419?
Clinical documentation must specify the nature of Rh incompatibility with hemolytic transfusion reaction, unspecified and any associated comorbidities for accurate reporting.
Cite this Clinical Reference